https://www.selleckchem.com/
The disease-free and overall survival rates were significantly shorter in type 2 patients than in type 1 patients (type 2 vs. type 1; 77% vs. 97%, 0.01, 94% vs. 100%, = 0.014, respectively). The univariate and multivariate analyses showed that there were no significant differences in disease-free survival between the lymphovascular space invasion-positive and -negative groups among type 1 cases. There was no difference in prognosis between patients with stage IA and type 1 endometrial cancer with and without lymphovascular space invasion. There was no
Like
Comment
Share
